). NT and SCD gRNAs had been obtained from genscript and well prepared in 293T cells. Efficacy of knockdown/overexpression was assayed by WB or qRT-PCR. All shRNA/gRNA sequences are presented in table S5. The application of SCD1 inhibitors, shown by both in vitro and in vivo types, may protect against https://freemany110jue2.p2blogs.com/profile